Mdxhealth Sa ADR (MDXH) Stock Price, Quote & News

Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolve...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: (866) 259-5644

Website: mdxhealth.com

Address:

CAP Business Center, Rue d’Abhooz 31 Zone Industrielle des Hauts-Sarts, Herstal, Belgium

thecontracap Oct. 17 at 2:29 AM

$MDXH consolidating for next run. Easily a double over next 12 months just to get to 3x rev!

0 · Reply

slick3333 Oct. 16 at 6:59 PM

$MDXH Mann I hate to see us break 4 the other day even though we didn’t close ….just going to be a long road to reverse and break 5 ….big news and increased revenue and profitability are key factors but hopefully we can hold on to $4 level till next earnings report….seem to be asking for a lot

1 · Reply

livingthehilife Oct. 13 at 3:24 PM

$MDXH dumped the whole position on Friday It was a good run⚡️

3 · Reply

slick3333 Oct. 10 at 2:45 PM

$MDXH looking like we won’t break 5 and will be on edge as we test resistance at 4

0 · Reply

slick3333 Oct. 8 at 6:36 PM

$MDXH which will we break first will likely tell us the direction $4 or $5??

0 · Reply

livingthehilife Oct. 7 at 4:45 PM

$SES I was buying this under a dollar : $SERV I was the fourth follower and buying it at $1.50 to $1.75 : we were purchasing this at $1.75. I still think it could hit six dollars super low flow if this ever gets any volume it could explode. : $MDXH

0 · Reply

livingthehilife Oct. 3 at 5:08 PM

$SES 🧨 : Super low float under 50 million outstanding shares $MDXH a little more volume, and this thing will explode : $SPY

0 · Reply

NVDAMillionaire Oct. 2 at 6:17 AM

$MDXH Brilliant piece that captures MDXH's situation perfectly. So if you want to update your understanding of MDXH or get to know MDXH better, this is essential reading. https://beyondspx.com/quote/MDXH/analysis/mdxhealth-mdxh-unlocking-growth-in-urology-diagnostics-with-precision-technology

0 · Reply

slick3333 Sep. 27 at 2:13 AM

$MDXH cant lie I was impressed with the recovery today!!

0 · Reply

Lukumon Sep. 26 at 6:02 PM

$MDXH $5 soon.

0 · Reply

Angle PLC Announces Strategy Update

Aug 5, 2025, 4:01 PM EDT - 2 months ago

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Jul 3, 2025, 1:00 PM EDT - 4 months ago

Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

May 14, 2025, 9:57 PM EDT - 5 months ago

MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:00 PM EDT - 5 months ago

MDxHealth Reports Q1-2025 Results

Feb 26, 2025, 8:57 PM EST - 8 months ago

MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:00 PM EST - 8 months ago

Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results

Jan 13, 2025, 5:00 AM EST - 10 months ago

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance

Dec 13, 2024, 10:15 AM EST - 11 months ago

MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics

Nov 25, 2024, 8:30 AM EST - 11 months ago

MDxHealth to Participate in Piper Sandler Healthcare Conference

Nov 8, 2024, 7:13 AM EST - 1 year ago

MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:00 PM EST - 1 year ago

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024

Sep 25, 2024, 9:31 PM EDT - 1 year ago

MDxHealth Announces Pricing of Offering of Ordinary Shares

Sep 25, 2024, 4:05 PM EDT - 1 year ago

MDxHealth Announces Launch of Offering of Ordinary Shares

Aug 22, 2024, 4:34 AM EDT - 1 year ago

MDxHealth SA (MDXH) Q2 2024 Earnings Call Transcript

Aug 21, 2024, 4:00 PM EDT - 1 year ago

MDxHealth Reports Q2 and Half Year 2024 Results

Aug 12, 2024, 4:00 PM EDT - 1 year ago

MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21

Jul 8, 2024, 8:00 AM EDT - 1 year ago

MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance

Jul 8, 2024, 8:00 AM EDT - 1 year ago

Mdxhealth Appoints Sanford J. Siegel, M.D.

May 15, 2024, 4:00 PM EDT - 1 year ago

Mdxhealth to Present at Upcoming Investor Conferences

May 4, 2024, 11:49 AM EDT - 1 year ago

MDxHealth SA (MDXH) Q1 2024 Earnings Call Transcript

May 1, 2024, 7:45 AM EDT - 1 year ago

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

Mar 12, 2024, 4:00 PM EDT - 1 year ago

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

Mar 6, 2024, 9:07 PM EST - 1 year ago

MDxHealth SA (MDXH) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 4:00 PM EST - 1 year ago

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

Feb 21, 2024, 5:00 PM EST - 1 year ago

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

Feb 16, 2024, 8:45 AM EST - 1 year ago

Mdxhealth Announces Resignation of Board Member

Jan 8, 2024, 4:00 PM EST - 1 year ago

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance

Dec 18, 2023, 1:00 AM EST - 2 years ago

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

Nov 27, 2023, 1:00 AM EST - 2 years ago

MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq

Nov 14, 2023, 4:00 PM EST - 2 years ago

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

Nov 11, 2023, 5:33 PM EST - 2 years ago

MDxHealth SA (MXDHF) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:00 PM EST - 2 years ago

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023

Nov 6, 2023, 1:00 AM EST - 2 years ago

MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

Oct 25, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8

Oct 20, 2023, 4:00 PM EDT - 2 years ago

Mdxhealth's New Share Capital Amount and New Number of Shares

Oct 9, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Preliminary Q3-2023 Revenues

Oct 2, 2023, 4:04 PM EDT - 2 years ago

MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting

Sep 26, 2023, 4:46 PM EDT - 2 years ago

Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer

Aug 23, 2023, 8:41 PM EDT - 2 years ago

MDxHealth SA (MXDHF) Q2 2023 Earnings Call Transcript

Aug 23, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Q2 and Half Year 2023 Results

Aug 10, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23

Aug 9, 2023, 4:00 PM EDT - 2 years ago

Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth's Select mdx for Prostate Cancer Test

Jun 30, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Announces Results of its Extraordinary General Shareholders' Meeting

Jun 5, 2023, 5:30 PM EDT - 2 years ago

MDxHealth Announces its Extraordinary General Shareholders' Meeting

May 25, 2023, 4:30 PM EDT - 2 years ago

MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings

May 23, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference

May 15, 2023, 9:24 PM EDT - 2 years ago

MDxHealth SA (MXDHF) Q1 2023 Earnings Call Transcript

May 15, 2023, 4:00 PM EDT - 2 years ago

MDxHealth Reports Q1-2023 Results

May 1, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present First Quarter 2023 Financial Results on May 15

thecontracap Oct. 17 at 2:29 AM

$MDXH consolidating for next run. Easily a double over next 12 months just to get to 3x rev!

0 · Reply

slick3333 Oct. 16 at 6:59 PM

1 · Reply

livingthehilife Oct. 13 at 3:24 PM

$MDXH dumped the whole position on Friday It was a good run⚡️

3 · Reply

slick3333 Oct. 10 at 2:45 PM

$MDXH looking like we won’t break 5 and will be on edge as we test resistance at 4

0 · Reply

slick3333 Oct. 8 at 6:36 PM

$MDXH which will we break first will likely tell us the direction $4 or $5??

0 · Reply

livingthehilife Oct. 7 at 4:45 PM

0 · Reply

livingthehilife Oct. 3 at 5:08 PM

$SES 🧨 : Super low float under 50 million outstanding shares $MDXH a little more volume, and this thing will explode : $SPY

0 · Reply

NVDAMillionaire Oct. 2 at 6:17 AM

0 · Reply

slick3333 Sep. 27 at 2:13 AM

$MDXH cant lie I was impressed with the recovery today!!

0 · Reply

Lukumon Sep. 26 at 6:02 PM

$MDXH $5 soon.

0 · Reply

slick3333 Sep. 23 at 2:32 PM

$MDXH bummer it was a nice run while it lasted ….was hoping we crossed 5 before the dump oh well…..

2 · Reply

livingthehilife Sep. 23 at 1:45 PM

$MDXH A push 2 5 Super low flot : $SPY

0 · Reply

slick3333 Sep. 22 at 7:41 PM

$MDXH 3x normal volume what the volume is going on!

0 · Reply

thecontracap Sep. 22 at 3:25 PM

$MDXH 3.5x rev is $8. $4X rev is $9.50. $VCYT grows half as fast and trades 4.5x.

1 · Reply

livingthehilife Sep. 22 at 2:46 PM

$MDXH : Super love float : $SPY

0 · Reply

slick3333 Sep. 21 at 5:01 PM

$MDXH man 4 was a big break and I m halfway to break even! Yes I went in too heavy to make a difference to average down a few years back…..next areas to watch is to hold 4 and clean breaks of 4.50 and 5 …..it’s finally nice to see them bring profit and I was/am a little worried about the acquisition but it’s the only way for them to grow faster….those acquisitions always cost more money to develop and take longer to turn into positive income

0 · Reply

thingkfast Sep. 20 at 1:11 PM

$MDXH 👀

0 · Reply

Rice1122 Sep. 19 at 5:27 PM

$MDXH I think people are finally seeing this company’s potential with recent performance and the future direction of the management team. Naturally expect it to dip below 4$ again as people take profits but I have a feeling that this stock will reach 6-7$ by end of year

0 · Reply

slick3333 Sep. 19 at 4:45 PM

$MDXH finally broke $4!!

0 · Reply

thecontracap Sep. 19 at 1:40 AM

$MDXH size-adjusted, $MDXH acquis of ExoDx is the best deal I’ve ever seen. Bio techne paid $250MM for it in 2018 before it even had reimbursement. Now it’s approved, generating $20MM+ of rev, growing 30% annually, and $MDXH bought it for… $5MM of stock and $10MM over the next 4 years?? Mgmt quality is everything in micro caps. Michael mcgarrity is a boss. $10 stock < 18 months

0 · Reply

livingthehilife Sep. 18 at 3:37 PM

$MDXH : All we need is a little volume over here. This is A 💎 Super low float : $SPY $TQQQ $TNA

0 · Reply

thecontracap Sep. 15 at 10:23 PM

$MDXH deal closed. Great news. November update going to be epic.

0 · Reply

Market Cap	208.07M
Revenue (ttm)	90.05M
Net Income (ttm)	-38.07M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-42.28%
Debt to Equity Ratio	-85.98

Volume	130,900
Avg Vol	169,600
Day's Range	N/A - N/A
Shares Out	47.29M
Stochastic %K	84%
Beta	1.65
Analysts	Strong Sell
Price Target	$6.50